Cite
MLA Citation
W. Townsend et al.. “S206: OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF THE GALLIUM STUDY.” HemaSphere, vol. 6, n.d., pp. 107–108. http://access.bl.uk/ark:/81055/vdc_100158013666.0x000005